Gene: PDZD11
Official Full Name: PDZ domain containing 11provided by HGNC
Gene Summary: Predicted to enable protein-macromolecule adaptor activity. Involved in pore complex assembly. Located in basolateral plasma membrane and cytosol. Part of pore complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22801 | PDZD11 Knockout cell line (HeLa) | Human | PDZD11 | 1:3~1:6 | Negative | Online Inquiry |
KO22802 | PDZD11 Knockout cell line (HCT 116) | Human | PDZD11 | 1:2~1:4 | Negative | Online Inquiry |
KO22803 | PDZD11 Knockout cell line (HEK293) | Human | PDZD11 | 1:3~1:6 | Negative | Online Inquiry |
KO22804 | PDZD11 Knockout cell line (A549) | Human | PDZD11 | 1:3~1:4 | Negative | Online Inquiry |
PDZD11 Gene Knockout Cell Lines are advanced cellular models designed to facilitate the study of the PDZD11 gene's role in various biological processes. By employing CRISPR/Cas9 gene-editing technology, these cell lines have been rendered incapable of expressing the PDZD11 protein, effectively creating a controlled environment to elucidate the gene’s functions and implications in cellular signaling and disease pathology.
The PDZD11 protein is known to be involved in processes such as cellular adhesion, immune response modulation, and signal transduction. The generated knockout cell lines allow researchers to systematically analyze the downstream effects of the absence of PDZD11, shedding light on its role in cellular behavior and potential contributions to conditions such as cancer and autoimmune disorders. This functionality makes these cell lines an invaluable tool for both basic research and translational studies aimed at designing targeted therapies.
One of the key advantages of our PDZD11 Gene Knockout Cell Lines is their specificity and reliability. Unlike traditional knockout models that may exhibit off-target effects or variability due to genetic background, our lines are rigorously validated to ensure that the knockout is precise and reproducible. This enhances the credibility of experimental results, providing researchers and clinicians with confidence in their findings.
Moreover, these cell lines can easily be incorporated into various experimental setups, including high-throughput screening and drug discovery applications, offering seamless integration into existing workflows. The availability of a well-characterized knockout model accelerates the research process and reduces the time and resources typically needed for gene editing.
Our company specializes in developing cutting-edge biological products that cater to the evolving needs of life science research. With a focus on precision and quality, we are committed to providing researchers and clinicians with tools that unlock new insights in the field of molecular biology. The PDZD11 Gene Knockout Cell Lines exemplify our dedication to advancing scientific inquiry and improving therapeutic outcomes through innovative solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.